Alternative Treatment Paradigm for Natalizumab Trial

Trial Profile

Alternative Treatment Paradigm for Natalizumab Trial

Withdrawn prior to enrolment
Phase of Trial: Phase II

Latest Information Update: 31 Dec 2016

At a glance

  • Drugs Glatiramer acetate (Primary) ; Methylprednisolone (Primary)
  • Indications Multiple sclerosis
  • Focus Therapeutic Use
  • Acronyms ATP
  • Most Recent Events

    • 02 Dec 2014 Status changed from not yet recruiting to withdrawn prior to enrolment, according to record.
    • 26 Apr 2013 Additional lead trial centres identified as reported by
    • 26 Apr 2013 Planned initiation date (Jul 2013) added as reported by
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top